Literature DB >> 18057166

The risk of antimalarials in patients with renal failure.

N Thorogood1, S Atwal, W Mills, M Jenner, D A Lewis, J D Cavenagh, S G Agrawal.   

Abstract

We present here a patient with end stage renal failure who received two weeks antimalarial prophylaxis at full dose leading to life threatening toxicity with severe acute megaloblastic anaemia, symptomatic pancytopenia and exfoliative dermatitis. Prompt recognition and treatment can rapidly reverse these fatal effects but more importantly, education of patients before travel is imperative in preventing such events.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18057166      PMCID: PMC2750932          DOI: 10.1136/pgmj.2007.063735

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  7 in total

1.  Haematological complications of proguanil in a patient with chronic renal failure.

Authors:  R A Sirsat; A Dasgupta
Journal:  Nephron       Date:  1997       Impact factor: 2.847

2.  Proguanil poisoning in a hemodialysis patient.

Authors:  J E Tattersall; R N Greenwood; L R Baker; W R Cattel
Journal:  Clin Nephrol       Date:  1987-08       Impact factor: 0.975

Review 3.  Acid-vesicle function, intracellular pathogens, and the action of chloroquine against Plasmodium falciparum.

Authors:  D J Krogstad; P H Schlesinger
Journal:  N Engl J Med       Date:  1987-08-27       Impact factor: 91.245

Review 4.  The biochemical basis of cobalamin deficiency.

Authors:  A Tefferi; R K Pruthi
Journal:  Mayo Clin Proc       Date:  1994-02       Impact factor: 7.616

5.  Megaloblastic anemia and pancytopenia due to Proguanil in patients with chronic renal failure.

Authors:  M Boots; M Phillips; J R Curtis
Journal:  Clin Nephrol       Date:  1982-08       Impact factor: 0.975

6.  Chloroquine as intercalator: a hypothesis revived.

Authors:  S R Meshnick
Journal:  Parasitol Today       Date:  1990-03

Review 7.  Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency.

Authors:  R H Allen; S P Stabler; D G Savage; J Lindenbaum
Journal:  FASEB J       Date:  1993-11       Impact factor: 5.191

  7 in total
  5 in total

1.  Pancytopenia due to proguanil toxicity in a returning traveller with fever.

Authors:  Hetty Jolink; Jan den Hartigh; Leo G Visser; Cees van Nieuwkoop
Journal:  Eur J Clin Pharmacol       Date:  2010-04-21       Impact factor: 2.953

Review 2.  Malaria prophylaxis in patients with renal impairment: a review.

Authors:  Sabine Amet; Sarah Zimner-Rapuch; Vincent Launay-Vacher; Nicolas Janus; Gilbert Deray
Journal:  Drug Saf       Date:  2013-02       Impact factor: 5.606

3.  Chronic use of chloroquine disrupts the urine concentration mechanism by lowering cAMP levels in the inner medulla.

Authors:  Tobias N von Bergen; Mitsi A Blount
Journal:  Am J Physiol Renal Physiol       Date:  2012-07-11

4.  Antimalarial drug and renal toxicity.

Authors:  Viroj Wiwanitkit
Journal:  J Nephropharmacol       Date:  2015-12-23

Review 5.  Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic.

Authors:  Efstathios Kastritis; Ashutosh Wechalekar; Stefan Schönland; Vaishali Sanchorawala; Giampaolo Merlini; Giovanni Palladini; Monique Minnema; Murielle Roussel; Arnaud Jaccard; Ute Hegenbart; Shaji Kumar; Maria T Cibeira; Joan Blade; Meletios A Dimopoulos
Journal:  Br J Haematol       Date:  2020-07-04       Impact factor: 8.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.